Motivational Program for Smokers Enrolled in a Methadone Maintenance Program

Sponsor
Butler Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00278226
Collaborator
National Cancer Institute (NCI) (NIH)
398
1
40
9.9

Study Details

Study Description

Brief Summary

RATIONALE: Stop-smoking programs may help patients stop smoking and prevent cancer from forming.

PURPOSE: This clinical trial is studying how well a motivational program works in helping smokers enrolled in a methadone maintenance program quit smoking.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: smoking cessation intervention
  • Other: educational intervention
N/A

Detailed Description

OBJECTIVES:
  • Determine the efficacy of a brief motivational intervention on smoking cessation in smokers enrolled in a methadone maintenance program.

OUTLINE: Patients are assigned to 1 of 2 groups.

  • Group 1: Patients undergo assessment at baseline and at 1, 3, and 6 months.

  • Group 2: Patients receive a brief motivational intervention at the time of their baseline assessment and undergo assessment as in group 1.

All patients will be offered a 2- to 3-month supply of nicotine patches.

PROJECTED ACCRUAL: A total of 400 patients will be accrued for this study.

Study Design

Study Type:
Interventional
Actual Enrollment :
398 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Smoking Cessation Among Methadone Maintained Patients
Study Start Date :
Jun 1, 2001
Actual Primary Completion Date :
Oct 1, 2004
Actual Study Completion Date :
Oct 1, 2004

Outcome Measures

Primary Outcome Measures

  1. Nicotine Abstinence [6-months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
DISEASE CHARACTERISTICS:
  • Must be currently enrolled in a methadone maintenance program

  • Smokes at least 10 cigarettes a day

PATIENT CHARACTERISTICS:
  • Not pregnant

  • No concurrent medical condition that precludes the use of nicotine patches

PRIOR CONCURRENT THERAPY:
  • No concurrent use of other nicotine replacement therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rhode Island Hospital Comprehensive Cancer Center Providence Rhode Island United States 02903

Sponsors and Collaborators

  • Butler Hospital
  • National Cancer Institute (NCI)

Investigators

  • Study Chair: Michael Stein, MD, Rhode Island Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00278226
Other Study ID Numbers:
  • CDR0000452798
  • R01CA084392
  • RIH-0076-98
First Posted:
Jan 18, 2006
Last Update Posted:
Mar 24, 2010
Last Verified:
Mar 1, 2010

Study Results

No Results Posted as of Mar 24, 2010